ANGELA ASTLEFORD: Open Payments
NPI 1124486790 · WOODSTOCK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 17 payments from 9 companies in 2025. Trend: 2023 $177 · 2024 $0 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $158 |
| Axsome Therapeutics, Inc. | 1 | $108 |
| Corium, LLC | 3 | $61 |
| Alkermes, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, Auvelity, Azstarys, ARISTADA, REXULTI, Qelbree, ZURZUVAE, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
